Brief: Heron Therapeutics Q2 net product sales USD 31.762 million
14/08/2023 23:27
Aug 14 (Reuters) - Heron Therapeutics Q2 EPS USD -0.35. * Q2 income from operations USD -42.403 million * Q2 net income USD -42.059 million * Q2 operating expenses USD 74.165 million * Q2 net product sales USD 31.762 million
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop